Bellevue Group AG Q1 2017 Filing

Filed May 11, 2017

Portfolio Value

$750.4B

Holdings

132

Report Date

Q1 2017

Filing Type

13F-HR

All Holdings (132 positions)

#StockSharesValue% PortfolioType
101
UTHUNITED THERAPEUTICS CORP DEL
7,800$1.1B0.14%
102
MEDICINES CO
21,500$1.1B0.14%
103
GKOSGLAUKOS CORP
20,000$1.0B0.14%
104
ICPTUSDINTERCEPT PHARMACEUTICALS IN
8,500$961.0M0.13%
105
INOINOVIO PHARMACEUTICALS INC
144,000$953.0M0.13%
106
JUNO THERAPEUTICS INC
37,000$821.0M0.11%
107
NVROEURNEVRO CORP
8,700$815.0M0.11%
108
ENVISION HEALTHCARE HLDGS INC
13,026$799.0M0.11%
109
QUOTIENT LTD
110,000$769.0M0.10%
110
MOHMOLINA HEALTHCARE INC
16,500$752.0M0.10%
111
GW PHARMACEUTICALS PLC
6,000$726.0M0.10%
112
HCSGHEALTHCARE SVCS GRP INC
16,500$711.0M0.09%
113
ALDER BIOPHARMACEUTICALS INC
33,000$686.0M0.09%
114
DVADAVITA INC
10,000$680.0M0.09%
115
PODDINSULET CORP
15,000$646.0M0.09%
116
VAREURVARIAN MED SYS INC
7,000$638.0M0.09%
117
IARTINTEGRA LIFESCIENCES HLDGS C
15,000$632.0M0.08%
118
CEMPRA INC
165,000$619.0M0.08%
119
CELLDEX THERAPEUTICS INC NEW
160,000$578.0M0.08%
120
RMERESMED INC
8,000$576.0M0.08%
121
TBPHTHERAVANCE BIOPHARMA INC
14,428$531.0M0.07%
122
TDOCTELADOC INC
20,000$500.0M0.07%
123
OBALON THERAPEUTICS INC
40,000$428.0M0.06%
124
REWALK ROBOTICS LTD
200,000$420.0M0.06%
125
ACHILLION PHARMACEUTICALS IN
99,000$417.0M0.06%
126
PENPENUMBRA INC
5,000$417.0M0.06%
127
NVAXNOVAVAX INC
325,000$416.0M0.06%
128
WEBMD HEALTH CORP
7,400$390.0M0.05%
129
AAC HLDGS INC
45,000$384.0M0.05%
130
MYGNMYRIAD GENETICS INC
13,000$250.0M0.03%
131
SGRYSURGERY PARTNERS INC
10,500$205.0M0.03%
132
CERSCERUS CORP
30,000$134.0M0.02%
PreviousPage 2 of 2